Real-world progression-free survival of first line afatinib patients with EGFR-mutant advanced lung adenocarcinoma: A multicentre study in Indonesia
ECOG performance status is a significant prognostic factor for PFS in patients treated with first-line afatinib. These real-world findings support its continued use and highlight the need for broader multicenter studies to validate the role of EGFR mutation subtypes in treatment outcomes.
Authors
- Chaliza Soliha (ORCID: https://orcid.org/0000-0002-4596-4626)
- Ida Ayu Jasminarti Dwi Kusumawardani (ORCID: https://orcid.org/0000-0002-2716-5222)
- Sri Melati Munir (ORCID: https://orcid.org/0000-0002-5274-8980)
- Ana Rima Setijadi (ORCID: https://orcid.org/0000-0001-7848-9588)
- Novita Andayani
- Wan‐Teck Lim (ORCID: https://orcid.org/0000-0002-4655-0206)
- Haryati Haryati (ORCID: https://orcid.org/0000-0001-8605-9991)
- Andreas Infianto
- Suryanti Dwi Pratiwi (ORCID: https://orcid.org/0000-0002-4733-7837)
- Avissena Dutha Pratama
- Laksmi Wulandari (ORCID: https://orcid.org/0000-0002-5000-0151)
- Elisna Syahruddin (ORCID: https://orcid.org/0000-0002-4383-2240)
- Noni Novisari Soeroso (ORCID: https://orcid.org/0000-0002-6668-9299)
- Muhammad Alfin Hanif
- Sabrina Ermayanti (ORCID: https://orcid.org/0000-0002-2956-9845)
- Natalie Duyan
Institutions
- Diponegoro University (ID)
- Sebelas Maret University (ID)
- Udayana University (ID)
- Lampung University (ID)
- University of Brawijaya (ID)
- Universitas Syiah Kuala (ID)
- Universitas Airlangga (ID)
- Universitas Sumatera Utara (ID)
- Sriwijaya University (ID)
- University of Indonesia (ID)
- Universitas Bandar Lampung (ID)
- National Cancer Centre Singapore (SG)
- Dharmais Cancer Hospital (ID)
- Lambung Mangkurat University (ID)
- Andalas University (ID)
- Riau University (ID)
Publication Details
- Journal
- Cancer Treatment and Research Communications
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ctarc.2025.100979
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00